Sign In
Buy VIR
$8.77
+0.0300 (+0.343%)
At Close: Jun 03, 2026
Oracle Investment Management Inc Buys Vir Biotechnology Inc, Atea Pharmaceuticals Inc, Guardant ...
02:38am, Wednesday, 17'th Nov 2021 GuruFocus
Related Stocks: VIR , FORA , SEM , AVIR , GH , MDGL , PTIX , XBIT , XBI , CAPR ,
MWG Management Ltd. Buys Illumina Inc, Sells Vir Biotechnology Inc
03:38pm, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: ILMN , VIR ,
Euclidean Capital LLC Buys Tenaya Therapeutics Inc, Surrozen Inc, Pinduoduo Inc, Sells PMV ...
03:38pm, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: PDD , TNYA , SRZN , DNLI , CNST , SNOW , NRIX , BEAM , VIR ,
Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Bought by Credit Suisse AG
10:24am, Tuesday, 16'th Nov 2021 Transcript Daily
Credit Suisse AG raised its position in Vir Biotechnology, Inc. (NASDAQ:VIR) by 450.2% in the second quarter, Holdings Channel reports. The institutional investor owned 58,173 shares of the companys stock after purchasing an additional 47,600 shares during the period. Credit Suisse AGs holdings in Vir Biotechnology were worth $2,751,000 as of its most recent filing []
Glaxo (GSK), Vir Intramuscular Sotrovimab Meets Study Endpoint
11:35am, Monday, 15'th Nov 2021
Glaxo (GSK) and Vir announce non-inferiority of intramuscular administration of sotrovimab compared to intravenous administration in reducing hospitalization or death as an early treatment of mild-to-
GSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19
09:37am, Friday, 12'th Nov 2021
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have announced topline data from COMET-TAIL Phase 3 trial evaluating sotrovimab delivered via Intramuscular (IM) administrati
Why Vir Biotechnology Stock Is Sliding Today
03:03pm, Friday, 05'th Nov 2021
Efficacy results for oral antivirals from Pfizer and Merck are weighing heavily on Vir today.
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2021 Financial Results on November 4, 2021
04:05pm, Thursday, 21'st Oct 2021
SAN FRANCISCO, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the third quarter en
SAN FRANCISCO, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that three abstracts highlighting data from its hepatitis B clinical program and one health outco
Vir Biotechnology to Participate in the H. C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference
04:05pm, Wednesday, 06'th Oct 2021
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., chief medical officer, is scheduled to present at the H. C. Wainwrig
VIR Stock Price: Why It Fell Over 21%
02:54pm, Saturday, 02'nd Oct 2021
The stock price of Vir Biotechnology Inc (NASDAQ: VIR) fell by over 21% in the previous trading session. This is why it happened.
Vir Biotechnology to Participate in the Guggenheim 2nd Annual Vaccine & Infectious Disease Day Conference
04:05pm, Thursday, 30'th Sep 2021
SAN FRANCISCO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., chief medical officer, is scheduled to present at the Guggenheim 2n
Why Vir Biotechnology Stock Is Sinking This Week
06:02am, Friday, 24'th Sep 2021
Shares fell after an analyst's downgrade.
Director Of Vir Biotechnology Sold $796.30 Thousand In Stock
12:45pm, Wednesday, 22'nd Sep 2021
Vicki Sato, Director at Vir Biotechnology (NASDAQ:VIR), made a large insider sell on September 17, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange C
Week 37 MDA Breakout Stocks - September 2021: Short-Term Picks To Give You An Edge
04:30am, Monday, 13'th Sep 2021
Two new Breakout Stocks for Week 37 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. Following the Momentum Gauges, the portfolio is u
